These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17987670)

  • 1. A semi-Markov model for multistate and interval-censored data with multiple terminal events. Application in renal transplantation.
    Foucher Y; Giral M; Soulillou JP; Daures JP
    Stat Med; 2007 Dec; 26(30):5381-93. PubMed ID: 17987670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. tdc.msm: an R library for the analysis of multi-state survival data.
    Meira-Machado L; Cadarso-Suárez C; de Uña-Alvarez J
    Comput Methods Programs Biomed; 2007 May; 86(2):131-40. PubMed ID: 17350136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A flexible semi-Markov model for interval-censored data and goodness-of-fit testing.
    Foucher Y; Giral M; Soulillou JP; Daures JP
    Stat Methods Med Res; 2010 Apr; 19(2):127-45. PubMed ID: 18765502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach.
    Faucett CL; Thomas DC
    Stat Med; 1996 Aug; 15(15):1663-85. PubMed ID: 8858789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiparametric estimation in a three-state duration-dependent Markov model from interval-censored observations with application to AIDS data.
    Frydman H
    Biometrics; 1995 Jun; 51(2):502-11. PubMed ID: 7662839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partly conditional survival models for longitudinal data.
    Zheng Y; Heagerty PJ
    Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interval-censored time-to-event and competing risk with death: is the illness-death model more accurate than the Cox model?
    Leffondré K; Touraine C; Helmer C; Joly P
    Int J Epidemiol; 2013 Aug; 42(4):1177-86. PubMed ID: 23900486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computing short-interval transition matrices of a discrete-time Markov chain from partially observed data.
    Charitos T; de Waal PR; van der Gaag LC
    Stat Med; 2008 Mar; 27(6):905-21. PubMed ID: 17579926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial multistate transitional models for longitudinal event data.
    Nathoo FS; Dean CB
    Biometrics; 2008 Mar; 64(1):271-9. PubMed ID: 17425639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An index approach for the Cox model with left censored covariates.
    D'Angelo G; Weissfeld L;
    Stat Med; 2008 Sep; 27(22):4502-14. PubMed ID: 18407573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The analysis of asthma control under a Markov assumption with use of covariates.
    Saint-Pierre P; Combescure C; Daurès JP; Godard P
    Stat Med; 2003 Dec; 22(24):3755-70. PubMed ID: 14673936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proportional odds model for multivariate interval-censored failure time data.
    Chen MH; Tong X; Sun J
    Stat Med; 2007 Dec; 26(28):5147-61. PubMed ID: 17476643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A generalized log-rank-type test for comparing survivals with doubly interval-censored data.
    Kim J; Kim YJ; Nam CM
    Biom J; 2009 Aug; 51(4):689-96. PubMed ID: 19650058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bias in Markov models of disease.
    Faissol DM; Griffin PM; Swann JL
    Math Biosci; 2009 Aug; 220(2):143-56. PubMed ID: 19538974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flexible B-spline model for multiple longitudinal biomarkers and survival.
    Brown ER; Ibrahim JG; DeGruttola V
    Biometrics; 2005 Mar; 61(1):64-73. PubMed ID: 15737079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonparametric estimation in a Markov "illness-death" process from interval censored observations with missing intermediate transition status.
    Frydman H; Szarek M
    Biometrics; 2009 Mar; 65(1):143-51. PubMed ID: 18505421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A penalized likelihood approach for an illness-death model with interval-censored data: application to age-specific incidence of dementia.
    Joly P; Commenges D; Helmer C; Letenneur L
    Biostatistics; 2002 Sep; 3(3):433-43. PubMed ID: 12933608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of nonhomogenous Markov models for analyzing longitudinal caries risk.
    Kopycka-Kedzierawski DT; Billings RJ
    Community Dent Oral Epidemiol; 2006 Apr; 34(2):123-9. PubMed ID: 16515676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model.
    Odell PM; Anderson KM; D'Agostino RB
    Biometrics; 1992 Sep; 48(3):951-9. PubMed ID: 1420849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAS macro program for non-homogeneous Markov process in modeling multi-state disease progression.
    Hui-Min W; Ming-Fang Y; Chen TH
    Comput Methods Programs Biomed; 2004 Aug; 75(2):95-105. PubMed ID: 15212852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.